Dinsmore & Shohl LLP
29 Jul 2024
Cipher Pharmaceuticals acquires global rights for Natroba™ from ParaPRO for US$89.5 million
Showing 1 to 1 of 1 entries
Case 136 | Deals 341
Case 106 | Deals 331
Case 142 | Deals 324
Case 238 | Deals 307
Case 79 | Deals 233